Acadia Pharmaceuticals ( ACAD) is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. This stock is trading up 16.6% at $2.18 in recent trading. Today's Range: $1.86-$2.21 52-Week Range: $0.90-$3.30 Volume: 1.8 million Three-Month Average Volume: 416,028 >>5 Breakout Stocks to Take From Twitter From a technical perspective, ACAD is spiking big today on monster volume. This sharp move higher has now pushed ACAD into breakout territory since the stock has moved above some near-term overhead resistance at $2.06. Market players should continue to look for long-biased trades as long as ACAD is trending above $2.06 and it closes near its daily highs of $2.20. If we get that strong close today, then look for ACAD to hit $2.40 to $2.60 in the near future.